Interleukin-1 receptor blockade in perinatal brain injury

Jason M. Rosenzweig, Jun Lei, Irina Burd

Research output: Contribution to journalReview article

Abstract

Interleukin-1 (IL-1) is a potent inflammatory cytokine that can be produced by a variety of cell types throughout the body. While IL-1 is a central mediator of inflammation and response to infection, the role of IL-1 signaling in adult and pediatric brain injury is becoming increasingly clear. Although the mechanisms of IL-1 expression are largely understood, the downstream effects and contributions to excitotoxicity and oxidative stress are poorly defined. Here, we present a review of mechanisms of IL-1 signaling with a focus on the role of IL-1 in perinatal brain injury. We highlight research models of perinatal brain injury and the use of interleukin-1 receptor antagonist (IL-1RA) as an agent of therapeutic potential in preventing perinatal brain injury due to exposure to inflammation.

Original languageEnglish (US)
Article number108
JournalFrontiers in Pediatrics
Volume2
Issue numberOCT
DOIs
StatePublished - Oct 1 2014

Keywords

  • IL-1
  • IL-1beta
  • Kineret
  • Perinatal brain injury
  • RIL-RA

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Interleukin-1 receptor blockade in perinatal brain injury'. Together they form a unique fingerprint.

  • Cite this